Literature DB >> 28705995

Reproducibility of airway luminal size in asthma measured by HRCT.

Robert H Brown1,2,3,4, Robert J Henderson5, Elizabeth A Sugar6, Janet T Holbrook5, Robert A Wise3.   

Abstract

Brown RH, Henderson RJ, Sugar EA, Holbrook JT, Wise RA, on behalf of the American Lung Association Airways Clinical Research Centers. Reproducibility of airway luminal size in asthma measured by HRCT. J Appl Physiol 123: 876-883, 2017. First published July 13, 2017; doi:10.1152/japplphysiol.00307.2017.-High-resolution CT (HRCT) is a well-established imaging technology used to measure lung and airway morphology in vivo. However, there is a surprising lack of studies examining HRCT reproducibility. The CPAP Trial was a multicenter, randomized, three-parallel-arm, sham-controlled 12-wk clinical trial to assess the use of a nocturnal continuous positive airway pressure (CPAP) device on airway reactivity to methacholine. The lack of a treatment effect of CPAP on clinical or HRCT measures provided an opportunity for the current analysis. We assessed the reproducibility of HRCT imaging over 12 wk. Intraclass correlation coefficients (ICCs) were calculated for individual airway segments, individual lung lobes, both lungs, and air trapping. The ICC [95% confidence interval (CI)] for airway luminal size at total lung capacity ranged from 0.95 (0.91, 0.97) to 0.47 (0.27, 0.69). The ICC (95% CI) for airway luminal size at functional residual capacity ranged from 0.91 (0.85, 0.95) to 0.32 (0.11, 0.65). The ICC measurements for airway distensibility index and wall thickness were lower, ranging from poor (0.08) to moderate (0.63) agreement. The ICC for air trapping at functional residual capacity was 0.89 (0.81, 0.94) and varied only modestly by lobe from 0.76 (0.61, 0.87) to 0.95 (0.92, 0.97). In stable well-controlled asthmatic subjects, it is possible to reproducibly image unstimulated airway luminal areas over time, by region, and by size at total lung capacity throughout the lungs. Therefore, any changes in luminal size on repeat CT imaging are more likely due to changes in disease state and less likely due to normal variability.NEW & NOTEWORTHY There is a surprising lack of studies examining the reproducibility of high-resolution CT in asthma. The current study examined reproducibility of airway measurements. In stable well-controlled asthmatic subjects, it is possible to reproducibly image airway luminal areas over time, by region, and by size at total lung capacity throughout the lungs. Therefore, any changes in luminal size on repeat CT imaging are more likely due to changes in disease state and less likely due to normal variability.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  asthma; computer tomography; precision

Mesh:

Year:  2017        PMID: 28705995      PMCID: PMC5668456          DOI: 10.1152/japplphysiol.00307.2017

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  28 in total

1.  Bronchodilation response to deep inspirations in asthma is dependent on airway distensibility and air trapping.

Authors:  George Pyrgos; Nicola Scichilone; Alkis Togias; Robert H Brown
Journal:  J Appl Physiol (1985)       Date:  2010-11-11

2.  Effect of Continuous Positive Airway Pressure on Airway Reactivity in Asthma. A Randomized, Sham-controlled Clinical Trial.

Authors:  Janet T Holbrook; Elizabeth A Sugar; Robert H Brown; Lea T Drye; Charles G Irvin; Alan R Schwartz; Robert S Tepper; Robert A Wise; Razan Z Yasin; Michael F Busk
Journal:  Ann Am Thorac Soc       Date:  2016-11

3.  Effect of bronchial thermoplasty on airway distensibility.

Authors:  R H Brown; W Wizeman; C Danek; W Mitzner
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

4.  Airway dimensions measured from micro-computed tomography and high-resolution computed tomography.

Authors:  J R Dame Carroll; A Chandra; A S Jones; N Berend; J S Magnussen; G G King
Journal:  Eur Respir J       Date:  2006-07-26       Impact factor: 16.671

5.  Inter-scan repeatability of CT-based lung densitometry in the surveillance of emphysema in a lung cancer screening setting.

Authors:  Sang Joon Park; Chang Hyun Lee; Jin Mo Goo; Chang Yong Heo; Jong Hyo Kim
Journal:  Eur J Radiol       Date:  2011-07-12       Impact factor: 3.528

6.  Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).

Authors:  Benjamin M Smith; Eric A Hoffman; Dan Rabinowitz; Eugene Bleecker; Stephanie Christenson; David Couper; Kathleen M Donohue; Meilan K Han; Nadia N Hansel; Richard E Kanner; Eric Kleerup; Stephen Rennard; R Graham Barr
Journal:  Thorax       Date:  2014-06-13       Impact factor: 9.139

7.  Identification of early interstitial lung disease in smokers from the COPDGene Study.

Authors:  George R Washko; David A Lynch; Shin Matsuoka; James C Ross; Shigeaki Umeoka; Alejandro Diaz; Frank C Sciurba; Gary M Hunninghake; Raúl San José Estépar; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu
Journal:  Acad Radiol       Date:  2009-09-24       Impact factor: 3.173

8.  Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.

Authors:  Sumit Gupta; Salman Siddiqui; Pranab Haldar; James J Entwisle; Dean Mawby; Andrew J Wardlaw; Peter Bradding; Ian D Pavord; Ruth H Green; Christopher E Brightling
Journal:  Thorax       Date:  2010-09       Impact factor: 9.139

9.  A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis.

Authors:  Ashley Busacker; John D Newell; Thomas Keefe; Eric A Hoffman; Janice Cook Granroth; Mario Castro; Sean Fain; Sally Wenzel
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

10.  Temporal variability in the responses of individual canine airways to methacholine.

Authors:  Robert H Brown; David W Kaczka; Katherine Fallano; Sining Chen; Wayne Mitzner
Journal:  J Appl Physiol (1985)       Date:  2008-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.